The technology really is incredible, I would love to see that study. The more I read about it the more interested I am in finding out more about it. It seems that MRNA really is going to be a leader in this field:
MDRNA is developing a diverse pre-clinical pipeline of therapeutics based on novel approaches utilizing proprietary RNAi technologies and delivery systems. First among these are the following development programs:
Oncology Metabolic disorders Inflammation
To fuel its pipeline, MDRNA is building one of the broadest and extensive patent estates in the RNAi field, with more than 260 filed patents addressing 144 gene sequences including numerous disease-validated targets.
Market Data 
Markets 
AI
